Hannah Whittaker is a Research Assistant in Statistics and Epidemiology at the National Heart and Lung Institute.
Hannah's current research uses electronic health records to investigate lung function decline in COPD patients.
Hannah obtained her MSc in Social Epidemiology from University College London in 2016 and has a BSc (Hons) in Biomedical Sciences (Pharmacology) from the University of Edinburgh.
et al., 2020, Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients, European Respiratory Journal, ISSN:0903-1936
et al., 2020, Eligibility for lung volume reduction surgery in chronic obstructive pulmonary disease patients identified in a UK primary care setting, Chest, Vol:157, ISSN:0012-3692, Pages:276-285
et al., 2019, Inhaled corticosteroids and FEV₁ decline in chronic obstructive pulmonary disease: a systematic review, Respiratory Research, Vol:20, ISSN:1465-9921
et al., 2019, Inhaled corticosteroids, blood eosinophils, and FEV1 decline in patients with COPD in a large UK primary health care setting, International Journal of Chronic Obstructive Pulmonary Disease, Vol:2019, ISSN:1176-9106, Pages:1063-1073
et al., 2018, RATE OF FEV1 DECLINE IN A PRIMARY CARE UK CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) POPULATION, Winter Meeting of the British-Thoracic-Society, BMJ PUBLISHING GROUP, Pages:A164-A165, ISSN:0040-6376